|
|
||||||||
2 Department of Biology and Department of Medicine, McMaster University, Hamilton, Ontario, Canada L8S 4K1; 3 Department of Zoology, Auburn University, Auburn, Alabama 36849-5414; and 1 Division of Marine Biology and Fisheries, Rosenstiel School of Marine and Atmospheric Science, University of Miami, Miami, Florida 33149
| |
ABSTRACT |
|---|
|
|
|---|
Electrical stimulation of a trout
saline-perfused trunk preparation resulted in metabolic and respiratory
responses comparable to those occurring after exhaustive exercise in
vivo. Recovery of intracellular acid-base status and glycogen
resynthesis were faster than in vivo. Intracellular carbonic anhydrase
(ICF CA) blockade elevated intracellular
PCO2 relative to untreated postexercise controls, whereas extracellular CA (ECF CA) blockade did
not, in contrast to previous work with muscle at rest. ECF CA blockade
had only a transient effect on postexercise
CO2 and ammonia efflux. The
relatively small pool of membrane-associated CA appears to be
overwhelmed by exercise-induced
CO2 production in muscle.
Transmembrane ammonia efflux appears to shift from diffusion primarily
as NH3 at rest, which is
facilitated by ECF CA, to movement predominantly as
NH+4 after exercise, which is independent of
CA. The postponed recovery of intracellular pH caused by either or both
ECF and ICF CA inhibition was consistent with reduced metabolic acid
and lactate excretion from muscle. Creatine phosphate resynthesis was
delayed by CA inhibition, whereas ATP replenishment was not affected.
Delayed glycogen recovery indicates that
HCO
3-dependent pathway(s) may be
involved in glyconeogenesis.
acid-base regulation; carbonic anhydrase inhibition; ammonia; energy-rich phosphates; glycolytic metabolism; benzolamide; acetazolamide
| |
INTRODUCTION |
|---|
|
|
|---|
CARBONIC ANHYDRASE (CA) catalyzes the reversible hydration/dehydration of CO2 as shown by
|
3).
Because of this, CA has been studied as an enzyme of respiratory
CO2 transport and excretion and as a metabolic enzyme that channels HCO
3
into various synthetic pathways (for reviews, see Refs. 16, 18, 41).
Nowhere is this multifunctional aspect of CA more apparent than in skeletal muscle, where CA is compartmentalized to the cytoplasm, the sarcolemma, the sarcoplasmic reticulum, and the mitochondria (reviewed in Refs. 16, 18). In mammals, CA has been shown to facilitate the excretion of CO2 across the sarcolemma in both type I (red, slow twitch, oxidative) and type II (white, fast twitch, glycolytic) fibers (11, 12). This prevents the buildup of CO2 in the intracellular fluid and the occurrence of an intracellular respiratory acidosis that would disrupt normal physiological and metabolic functions. This pattern appears to hold for lower vertebrates as well. Sarcolemmal CA appears to facilitate the movement of CO2 out of resting trout white muscle, and both sarcolemma and cytoplasmic CA appear to be involved in the efflux of NH3 (20).
This is interesting from an evolutionary point of view because the prevailing paradigm has always been that the aquatic medium, due to its high capacitance for CO2, did not exert any selective pressure on the development of physiological mechanisms for CO2 transport and excretion. The fact that a relatively large fluid compartment such as blood or water could act as a virtually unlimited sink for CO2 was considered the most important factor in shaping the mechanisms of CO2 excretion in aquatic vertebrates (41). Similar arguments have been made for NH3 excretion. (e.g., Ref. 3). However, membrane-associated CA oriented toward the extracellular fluid has now been shown to be important in facilitating both CO2 and NH3 fluxes across the sarcolemma, even in the presence of relatively small PCO2 and NH3 pressure (PNH3) gradients, in the latter case by providing H+ ions for diffusion trapping of NH3 as NH+4 (19). Those findings are in general agreement with the prevailing idea in mammalian physiology that the relatively small amount of membrane-associated CA functions in directional transport and the much larger pool of cytoplasmic CA functions primarily in maintaining instantaneous equilibrium among the chemical species of CO2 in the intracellular fluid (ICF; Ref. 24). Our earlier study (20) of the transport function of CA in a lower vertebrate was performed on a resting perfused trout muscle preparation with a low metabolic rate. Sarcolemma-associated CA makes up only ~5% of the total muscle CA activity in this preparation, with the cytoplasmic pool comprising almost all of the remaining balance. Therefore, it would be interesting to know if that particular subcellular fraction of CA remains the functionally important component in CO2 excretion under conditions of maximal CO2 production (i.e., exercise) or whether the larger pool of cytoplasmic CA becomes more significant.
It would also be interesting to know whether the role of either or both fractions of muscle CA becomes more important after strenuous exercise, when NH3 production in muscle becomes greatly elevated because of adenylate deamination (28, 40). Our recent work suggests that muscle cell membrane permeability to ammonia alters markedly after strenuous exercise, such that its NH+4 permeability increases relative to its NH3 permeability at this time (43, 45). As a result, ammonia distribution becomes more dependent on the membrane potential (which sets the electrochemical gradient governing NH+4 movements) and less dependent on the pH gradient (which sets the PNH3 gradient governing NH3 movements). This appears to help retain ammonia in muscle for adenylate resynthesis (see Refs. 49, 50). If this is the case, then the importance of CA in promoting ammonia efflux by NH3 diffusion trapping might become less important after exercise.
With respect to the role of CA in metabolism, the liver has been the
major organ of focus in mammals because it is the primary site of
ureagenesis and gluconeogenesis (along with the kidney); skeletal
muscle has been less thoroughly studied. However, in mammals it is
known that CA inhibition alters skeletal muscle contractile properties,
utilization of metabolic substrates, and accumulation of metabolic
intermediates and end products, especially during exercise (9, 11, 19).
However, detailed studies on the exact role(s) of CA in these processes
are lacking. In the relatively few lower vertebrates that have been
investigated, the hepatic Cori cycle appears to be much less important
than in mammals, and significant gluconeogenesis occurs in several other tissues, including skeletal muscle (4, 8, 14, 15). In teleost
fish (in contrast to most higher vertebrates), there is now strong but
circumstantial evidence that glyconeogenesis occurs in white muscle,
but the exact metabolic pathway involved has never been elucidated (26,
29, 37, 48). Three potential routes for lactate (Lac) reprocessing in
fish have been proposed, two of which involve a carboxylation step that
would suggest the involvement of CA (i.e., carboxylation of pyruvate
either via pyruvate carboxylase or via the reversal of malic enzyme;
Refs. 14, 26, 30). The third involves the conversion of pyruvate to
phosphoenolpyruvate via the reversal
of pyruvate kinase (37) and therefore would be independent of
HCO
3 and presumably independent of CA
activity as well. Evidence as to the involvement or noninvolvement of
CA in the process of glyconeogenesis from Lac would certainly help
clarify the pathway(s) involved.
Another potential involvement of CA is in phosphagen metabolism. In mammals, CA inhibition has been reported to cause the breakdown of creatine phosphate (PCr) and an increase in ADP and inorganic phosphate (9, 11). Whether the breakdown of energy-rich phosphates is the result of respiratory acidosis remains unclear. In strenuously exercised trout white muscle, PCr is severely depleted, whereas ATP is less affected, but the former recovers much more quickly in parallel to the clearance of postexercise respiratory acidosis (43). Possibly, elevated PCO2 acts as an end product inhibitor of pyruvate decarboxylation, thereby setting an upper limit to the rate of the tricarboxylic acid cycle and PCr resynthesis.
In this study, we have modified our isolated-perfused trout tail trunk preparation (19, 45) so that it can be exercised in situ. The preparation has been used to study the transport and metabolic roles of CA in white muscle under conditions of both exercise and postexercise recovery. Specifically, with respect to transport, the question of what roles sarcolemma and/or cytoplasmic CA play in facilitating the transport of CO2 and NH3 across the trout muscle cell membrane has been addressed under conditions of greatly increased CO2 and NH3 production. With respect to metabolism, the potential roles of the two muscle CA pools in Lac clearance, glycogen (Gly) resynthesis, and phosphagen dynamics after exercise have all been investigated. The results demonstrate the importance of multiple functions of both muscle CA pools in the exercise and postexercise physiology of the rainbow trout.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Rainbow trout (Oncorhynchus
mykiss Walbaum) were purchased from
Spring Valley Trout Farm, Petersburg, ON, Canada. The fish (initially
400-600 g) were held in two 800-liter fiberglass aquariums for
4-6 mo to grow to the desired size (700-1,000 g) before the experiment. Dechlorinated Hamilton tap water (meq/l; 0.6 Na+, 0.8 Cl
, 1.8 Ca2+, 0.5 Mg2+, 0.04 K+; pH 8.0, temperature
5-14°C) was supplied to the fish holding tanks. The trout were
fed with high-protein floating pellets (Aquaculture Zeigler Brothers)
three times a week. However they were not fed for 5 days before an
experiment, during which time they were kept at 15 ± 1°C.
Metabolic rate and ammonia production in fish are extremely sensitive
to feeding status; we have found that 5 days of starvation is
sufficient to achieve stable O2
consumption and ammonia production rates in trout of this size, without
significant depletion of muscle Gly reserve (C. M. Wood, unpublished
data). Before perfusion, the experimental fish were anesthetized with a
high concentration of MS-222 (0.5 g/l neutralized with NaOH); fish
usually lost equilibrium and ceased ventilation within 1 min without
struggling. The tail portion was then severed by section at a point
immediately posterior to the anus and weighed. In addition, in the
control series (see below), an initial muscle sample was excised from a
point immediately anterior to the point of section (see below). The
fish was then killed by a blow on the head.
Experimental design and protocols. An
isolated tail trunk perfusion preparation developed earlier by our
laboratory was employed in this study (refer to Ref. 45 for a detailed
description). In brief, Cortland salmonid saline with 3% (wt/vol) BSA
(fraction V, Sigma) was used as the basic perfusate. The perfusate was
saturated with oxygen, whereas PCO2
was kept constant at ~2 Torr (i.e., ~0.25%
CO2, balance
O2). Perfusate pH was adjusted
to the desired level by varying
NaHCO3 concentration. Immediately
after the tail trunk was cut off, catheters (Clay-Adams PE-90) were implanted into the caudal artery and vein and a ligature around the vertebral column was applied to secure them in place. The perfused
tail trunk was placed in a thermocontrolled (15 ± 1°C) saline bath, and the perfusate was also equilibrated to the same temperature before entering the trunk. The standard perfusion rate was
2 ml · min
1 · 100 g
1 tail weight. For the
first 30 min, a heparinized perfusate (50 IU/ml at pH 7.9; to simulate
resting arterial pH values) was employed to purge red blood cells and
to stabilize the preparation. After the initial 30 min, heparin-free
perfusate was used. Venous (outflow) followed by arterial (inflow)
perfusate samples [2 ml, representing time
0 (T0)] were then collected
through sampling ports with the use of gas-tight Hamilton syringes.
Immediately after the initial 30-min perfusion and perfusate sampling, exhaustive exercise was induced by the direct electrical stimulation of trunk muscle while perfusion at pH 7.9 continued. Shielded bipolar platinum electrode pads were placed on both sides of the tail trunk and held in place by a gauze bandage. Muscle was stimulated for 4 min at 100 V, 20-ms pulse duration, and 10 pulses/s frequency, with the polarity being altered at 15-s intervals to exercise the muscle in an undulatory manner similar to that of natural swimming. Muscle fatigue and exhaustion were noted as a lack of response to the stimulation toward the end of the 4-min exercise period.
After stimulation, the tail trunk was perfused with saline adjusted to
a pH of 7.4 to simulate in vivo postexercise arterial acid-base
conditions (43). Venous and arterial perfusate samples were then taken
at 5 (T5), 15 (T15), and 30 (T30) min postexercise as described
above. Part of the arterial and venous perfusate samples was used to
measure pH, total CO2
(TCO2),
PO2, protein, and water content
immediately on sampling. Aliquots (300 µl) of each were deproteinized
in 600 µl of 6% perchloric acid (PCA) and stored at
70°C
for later analysis of ammonia (Amm) and Lac concentrations, while the
remainder of the sample was used to measure
Na+,
K+, and
Cl
concentration.
Four experimental series were performed: a control and three
experimental treatments (Table 1). In all
series, a final muscle sample (3-5 g; in the dorsal area above the
lateral line) was excised from the perfused tail trunk at the end of
each 60-min experiment, representing
T30 in the protocol. The tissue
samples were freeze-clamped quickly with aluminum tongs prechilled in liquid N2 and then stored in
liquid N2 for later analysis of
pHi, muscle tissue water content,
and
TCO2,
Lac, Amm, Gly, ATP, PCr, Na+,
K+, and
Cl
concentrations.
|
The control series employed a drug-free perfusate (pH 7.9 before and during exercise, pH 7.4 thereafter) throughout the experiment. In the control series only, at the start of each experiment, immediately after the tail was cut off, a muscle tissue sample (3-5 g, same location) was taken from a point just anterior to the section to serve as a reference for resting in vivo levels of tissue metabolites and electrolytes. Also, in the control series only, two extra sets of preparations were run (i.e., additional to the preparations that ended at T30). These were terminated at 5 (T5) and 15 (T15) min after exercise, so that muscle samples could be taken at these times to establish a more detailed profile of the postexercise changes in muscle pHi and metabolic status.
In the first experimental treatment, a CA inhibitor of low membrane permeability, benzolamide (BZ), was used to selectively block CA activity in the extracellular fluid (ECF) (BZECF). Immediately after the initial 30-min perfusion to wash out red blood cells and the 4 min of exercise, the drug-free perfusate (pH 7.9) was changed to one containing 10 µM BZ (pH 7.4) for another 30 min. A perfusate BZ concentration of 10 µM (~1,000 × the inhibition constant) was applied to achieve ECF CA inhibition while avoiding ICF CA inhibition (13). Arterial and venous perfusate samples (T5, T15, T30) and muscle samples (T30) were collected as described above. Unlike our study on resting fish where quaternary ammonium sulfanilamide (QAS) was used to inhibit the ECF-oriented CA (20), BZ was chosen in the present study because, in our preliminary tests, QAS was found to retard the response of the tail trunk to the electrical stimulation. Furthermore, because CA inhibition in skeletal muscle is known to inhibit various mechanical and metabolic aspects of contraction (see introduction), BZ was not introduced to the tail trunk until the exercise routine was completed.
The second experimental treatment used the common, more membrane-permeable CA inhibitor acetazolamide (AZ) to inhibit ICF (cytoplasmic) CA only (AZICF) by a previously established protocol (20). At 12-16 h before the experiment, fish were anesthetized, weighed, and injected via caudal puncture with sufficient stock solution of 100 mM AZ to produce an initial extracellular concentration of 100 µM, assuming an ECF volume (ECFV) of 25% of the fish's weight. The fish were left for 12-16 h in individual, darkened acrylic boxes served with aerated flowing water, thereby allowing the AZ sufficient time to equilibrate between the ECF and the muscle ICF. For the first 30 min of control perfusion, the perfusate contained 100 µM AZ (pH 7.9) to maintain full ICF inhibition. However, AZ was not used in the 30-min postexercise perfusate (pH 7.4) so as to wash the AZ out of the extracellular space. In this case, ECF CA activity would be restored, whereas the inhibition to ICF CA would remain due to the slow membrane permeability of AZ (20). Perfusate samples were taken at T5, T15, and T30, and muscle samples were taken at T30.
The third experimental treatment evaluated the effect of total CA inhibition (ICF and ECF CA blockade, AZtot). Again, the fish were first preinjected with AZ as described above. In contrast, the tail trunks were perfused with 100 µM AZ for the entire 60 min of perfusion (i.e., for 30 min preexercise at pH 7.9 and for 30 min postexercise at pH 7.4). Our previous study demonstrated that this protocol produced the highest level of CA inhibition (84.8%) of all three treatments (20). Perfusate samples were taken at T5, T15, and T30, and muscle samples were taken at T30.
Finally, all data for resting conditions, i.e., perfusate and muscle acid-base status, muscle metabolites, and metabolite fluxes, were obtained from muscle and perfusate samples taken during our earlier study on resting tail trunks (20). These preparations were perfused for the same period of time (but at pH 7.9 throughout), subjected to either a control perfusion (no drugs) or a similar treatments with CA inhibitors, and sampled at T30 (but without exercise). Extracellular CA inhibition was achieved using QAS. However, ion flux rates were not measured in our previous study on resting preparations. Therefore T0 values collected before the exercise regimen were used as the reference points for the postexercise ion flux data. Note that because ECF CA blockade was applied only after exercise, the reference point is not parallel for this treatment only.
Analytic protocols. Perfusate pH was
measured with a Radiometer glass capillary electrode (G297-G2 and K497
calomel reference electrode) thermostatted to 15 ± 1°C and
registered on a Radiometer PHM84 pH meter.
PO2 was determined using a
thermostatted Radiometer PO2
electrode (E5046) connected to PHM72 meter. Total
O2 content was calculated based on
the measured PO2 (Torr) and the
solubility coefficient
O2 (1.77 µmol · l
1 · Torr
1)
at 15°C (2).
TCO2 was
measured on 100 µl perfusate sample using a total
CO2 analyzer (Corning 965).
PCO2 and the concentration of
HCO
3
([HCO
3]) were calculated
by rearrangement of the Henderson-Hasselbalch equation with appropriate
constants (
CO2 and pK')
for trout plasma at 15°C (2). Perfusate ion concentrations
([Na+],
[K+], and
[Cl
])
measurements were conducted on a specific electrode (AVL 983-S Electrolyte Analyzer). The perfusate Lac and total Amm
(TAmm) concentrations were
determined by the Sigma
L-lactate dehydrogenase and
glutamate dehydrogenase assays (both NAD/NADH coupled), respectively. The perfusate total protein and water content were determined with a
refractometer (American Optical). The nonbicarbonate buffer capacity
(
=
5.54 ± 0.15 mM
[HCO
3] pH unit) of the perfusate was determined in a previous study (45).
One portion of each freeze-clamped muscle sample was stored in liquid
N2 and later pulverized in liquid
N2 with an insulated mortar and
pestle. An aliquot (~200 mg) of this muscle tissue powder was used to
measure intracellular pH (pHi)
and
TCO2 (TiCO2 ) with the homogenization technique
(33). Intracellular PCO2 and
[HCO
3] were calculated
using the Henderson-Hasselbalch equation as outlined above, after
appropriate correction of TiCO2 values for
trapped ECF
TCO2
(see below). A second aliquot (~100 mg) of tissue powder was
deproteinized in 1 ml 8% PCA and stored in liquid
N2 for tissue ammonia analysis by
a modified glutamate dehydrogenase method (23). A third, much larger
aliquot was lyophilized for 64 h and used for tissue PCr, ATP, Gly,
Lac, and ion analysis. Muscle PCr, ATP, and Gly concentrations were analyzed by standard enzymatic techniques (1).
Tissue Lac was determined by the same enzymatic assay described above.
For tissue Na+,
K+, and
Cl
measurements, the
freeze-dried tissue powder (~20 mg) was extracted in 1N
HNO3 (1 ml) at 50°C for 48 h.
The supernatant was used for [Na+] and
[K+] analysis by flame
atomic absorption spectrometry (Varian AA-1275). Tissue
[Cl
] was
measured by coulometric titration (Radiometer CMT10). A common standard
was used to calibrate all the ion measurements in both perfusate and
muscle tissue.
A second portion of muscle tissue (nonpulverized; 200-300 mg) was used to determine the muscle tissue water content by drying at 70°C in an oven for over 48 h to constant weight.
In addition, in the BZ series, another portion of nonpulverized muscle tissue was shipped to Auburn University on dry ice and used for muscle CA activity measurement. For the other groups, muscle CA activities were taken from measurements on identical protocols in our previous study (20). For this assay, frozen tissue (~250 mg) was homogenized for 30 s in 2 ml buffer (in mM: 75 mannitol, 225 sucrose, 10 Tris-PO4, pH 7.4) with the use of an Omni 1000 motor-driven homogenizer and then sonicated (35 W, 15 s, Heat Systems Microson) and centrifuged at 10,000 g for 20 min at 4°C (Sorvall RC5-B). The supernatant was analyzed for CA activity at 4°C by the electrometric pH method (17).
Calculations. Metabolic acid
(
H+m) added to the perfusate from the
perfused muscle trunk was calculated according to Milligan and Wood
(27)
|
Flux rates of Lac, TAmm,
H+m, total
CO2,
O2, and ions
(Na+,
K+, and
Cl
) were calculated
according to the Fick principle using the perfusion rate (1.2 l · kg
1 · h
1
) and the differences in concentration between arterial inflow and
venous outflow.
Intracellular fluid volume (ICFV) and ECFV were calculated based on
water content, [K+],
and [Cl
] in
whole muscle tissue and venous perfusate using the
"Cl
K+ space" concept of Conway (5)
described earlier (45). All intracellular metabolite and electrolyte
concentrations were corrected for trapped ECF content in whole muscle
tissue and expressed per unit ICF water, whereas the concentrations in
the perfusate were expressed per unit ECF water.
Statistical analyses. Data are
presented as means ± SE (n),
where n represents the number of
preparations in each treatment group. The
F test was performed to identify any
significant differences in variance between the treatment and control
groups or between the resting and postexercise groups in each
treatment, then appropriate t-tests
were performed to assess whether differences existed between the tested
groups (P
0.05). One-way ANOVA and
Duncan's multiple-range and critical range test were performed for
multiple comparisons with reference to the control
(P
0.05).
| |
RESULTS |
|---|
|
|
|---|
The exercise protocol introduced by electrical stimulation resulted in vigorous muscle contraction in the control group and in all experimental groups, with the muscle exhausting gradually toward the end of the 4-min exercise regimen. The BZ treatment was not applied until immediately after the end of exercise. The two AZ treatment groups did not show any signs of earlier exhaustion or less muscle contraction as suggested in studies on higher vertebrates (10, 11). The perfusion pressure increased by ~5 cmH2O immediately after exercise, but returned to the original level (~10 cmH2O) within 10 min.
AZICF and AZtot treatments, applied exactly as in the present study, resulted in 77.8 and 84.8% inhibition, respectively, of CA activity in the perfused tail trunk muscle (20); for methodological reasons, these are believed to be conservative estimates. In contrast, BZ treatment resulted in only a 38.0% inhibition of CA activity, which is almost identical to the 40.4% inhibition rate reported earlier for the other ECF CA inhibitor QAS (20).
Acid-base status and gas exchange. At rest, the pHi of perfused white muscle was ~7.28, comparable to the in vivo value of 7.25 ± 0.02 (n = 8) measured at the time of death, and after exercise decreased by ~0.6 units to 6.73 at T5 in the control series (Fig. 1). This change, occurring after 4 min of in situ electrical stimulation of the perfused tail trunk, was comparable to reported values in the white muscle of intact trout under commonly used in vivo exercise protocols, such as 6 min of hand chasing (27, 37, 39, 43). However, in contrast to the in vivo situation where either a further decrease or no change in pHi occurs by 30 min, pHi recovered relatively quickly to 6.82 at T15 and 7.07 at T30 in the control group. This value was still significantly lower than the initial in vivo resting pHi and the resting values in perfused preparations.
|
In the three experimental groups treated with CA inhibitors, muscle pHi at rest (data reported in 20) remained at the control resting levels. Postexercise pHi measurements were taken only at T30; in comparison with corresponding resting values, pHi remained much more depressed at this time in all three treatments (Fig. 1). AZICF produced the greatest depression of postexercise pHi (6.89), whereas BZECF produced the least depression (6.99). In all three cases, these differences were significant relative to the control pHi at T30.
Before exercise (T0), outflowing
perfusate pH (pHv) was ~0.1
unit below the inflowing pHa of
~7.90 in both control and experimental series. The resting
arterial-venous (a-v) difference in pH
(T30) showed the same pattern (Fig.
1). In the control series, this difference increased after exercise to
~0.3 units below the new inflowing
pHa of 7.40. These values remained
stable at T5,
T15, and
T30. In all three CA inhibition
treatments, the outflowing perfusate
pHv values were significantly
higher compared with the corresponding control values at
T15 and
T30, and also at
T5 in the
BZECF treatment only. Thus the
pHa
pHv difference decreased significantly at these times relative to the control series, especially in BZECF series. These higher pH
values in the outflowing perfusate reflected the slower correction of
intracellular acidosis in the three treatment groups (Fig. 1).
Before exercise (T0), the outflowing perfusate PCO2 (PvCO2) was ~3.5 Torr relative to an inflowing PCO2 (PaCO2) of ~2 Torr (Fig. 2A). After exercise, PvCO2 increased ~2.5-fold at T5, declining only slightly by T30 in the control group (Fig. 2A). CA blockade did not affect PvCO2 at rest, and the same general postexercise pattern was seen in all three treatment groups. However, the postexercise PvCO2 elevation was significantly attenuated throughout the recovery period by the BZECF treatment and at T30 by the AZICF treatment (Fig. 2A), in general agreement with the pHv data (Fig. 1).
|
In this perfused trunk preparation, resting muscle had an intracellular
PCO2 of 7.31 ± 0.63 Torr
(n = 8) and an intracellular TCO2 of
6.21 ± 0.61 mM (n = 8), both
marginally higher (0.10
P
0.05)
than the in vivo values measured at the time of death
(PCO2 = 5.54 ± 0.76 Torr,
n = 8;
TCO2 = 4.69 ± 0.61 mM, n = 8). These
resting values in the perfused muscle were unaffected by
AZICF or
AZtot treatment, but extracellular inhibition significantly elevated intracellular
PCO2 without a significant change in
TCO2 (Fig. 2,
A and
B; data reported in Ref. 20).
Compared with resting muscle, exercise in the control series resulted in a 75% increase in intracellular PCO2 to ~13 Torr at T30 (Fig. 2A), but intracellular TCO2 was not significantly elevated (Fig. 2B). Relative to the control group at T30, intracellular PCO2 was slightly elevated by CA blockade in all three treatment groups (significant only in the AZICF treatment; Fig. 2A), whereas intracellular TCO2 remained unchanged (Fig. 2B). TCO2 efflux in the control group increased by more than twofold immediately after exercise and declined slightly (28%) during the following 30 min of recovery (Fig. 3). BZECF inhibition significantly depressed this postexercise TCO2 efflux by ~25%, an effect that was significant at both T5 and T30. The TCO2 efflux rates after exercise were not affected by AZICF and AZtot inhibition (Fig. 3).
|
In comparison with the control resting O2 consumption rate (MO2), the stimulation protocol did not induce a significant increase in MO2 (Table 2). Relative to appropriate resting MO2 values or to simultaneous control values, the AZtot group exhibited a small decrease and the AZICF and BZECF group exhibited essentially no change in MO2. Notably, the postexercise elevation in TCO2 efflux significantly exceeded the increase in MO2 in all groups (Fig. 3, Table 2). The nonstoichiometric changes in TCO2 efflux and O2 uptake led to a "respiratory quotient" of >1.0. This result is in agreement with our previous observations in resting perfused muscle and suggests that the entire TCO2 efflux was not directly derived from oxidative metabolism in mitochondria (20).
|
At rest,
H+m flux in the control group
was slightly negative, indicating metabolic acid uptake by the muscle
(Fig. 4). With exercise,
H+m flux shifted to positive values at
T15 and
T30, indicating an unloading of
metabolic protons from the muscle. At rest,
AZtot and
AZICF CA inhibition had no effect
on the direction of
H+m, but
extracellular CA inhibition resulted in
H+m efflux. In contrast, CA blockade,
in all treatments, significantly altered this pattern of postexercise
H+m flux, which remained negative
(i.e., inwardly directed) throughout the 30-min recovery period (Fig.
4). This inhibition of metabolic proton efflux was greatest in the
AZtot treatment and least in the
BZECF, a difference that was
significant only at T30. The depressed
H+m influx in the
BZECF group after exercise (e.g.,
T30) was consistent with the
elevated
H+m efflux caused by
extracellular CA inhibition at rest. In general these effects
agreed well with the lower values of
pHi and higher values of
pHv accompanying CA inhibition
seen in Fig. 1.
|
Effects on ammonia metabolism. Ammonia
efflux rates (Fig. 5) were variable within
each treatment group but were generally lower than
H+m flux rates (Fig. 4), or
approximately 10% of
TCO2 efflux
rates (Fig. 3). Ammonia efflux was unaffected by CA
inhibition at rest, and the efflux rates increased by more than
fivefold after exercise in the control series (Fig. 5). ECF CA blockade
with BZECF reduced this
postexercise increase by ~50% at 15 min; however, the attenuation
was only transient. AZtot and
AZICF also led to minor,
nonsignificant reductions (Fig. 5). It was our intention to measure
transmembrane ammonia gradients, as was done in the previous study at
rest (20), but unfortunately, most of the muscle samples were lost in
the failure of the ultra-cold freezer in which they were stored. As a
result, intracellular ammonia was only measured in vivo at the time of
death (323 ± 37 µM, n = 8) and
at rest (T30 of perfusion: 259 ± 57 µM, n = 8) and in the control
group at T15 (4,199.97 ± 632.91 µM, n = 5) and
T30 postexercise (2,031.82 ± 586.35 µM, n = 5).
|
Effects on energy-rich phosphates metabolism. Resting muscle PCr and ATP concentrations in the perfused tail trunk measured at T30 of perfusion were comparable to those measured in vivo at the time of death (Table 3). In parallel with experiments performed on intact fish in vivo (37, 43), muscle PCr in the perfused tail trunk was almost depleted by exhaustive exercise and was largely but not completely recovered after 30 min (Table 3). In contrast, ATP levels were only moderately reduced after exercise, an effect that persisted at T15 and T30.
|
CA inhibition had no effect on muscle ATP levels at rest or on the ~20% depression seen at T30 (Table 3). However, the effects of CA inhibition on PCr metabolism were pronounced. Under resting conditions, total and ECF CA inhibition reduced PCr reserves to 43 and 67% of control resting levels, respectively. However, under ICF CA blockade, PCr concentrations remained at control resting levels (Table 3). In the postexercise state, the effects of CA inhibition were rather different. Muscle PCr concentrations at 30 min postexercise in the AZtot and BZECF treatment groups remained significantly below the corresponding control levels (T30), and they did not differ from their initial resting values (Table 3). However, the AZICF treatment, which had not affected PCr levels at rest, resulted in the largest depression at T30 postexercise (Table 3). These results suggest that ECF CA activity may play a role in maintaining the resting muscle PCr levels, whereas ICF CA activity may be important for PCr recovery.
Effects on glycolytic metabolism and Lac efflux. Resting muscle Gly concentrations (~40 mM) measured at T30 in the perfused tail trunk were high relative to most in vivo studies (reviewed in Ref. 3) but were internally consistent; unfortunately in vivo samples taken at the time of death in the present study for comparison were lost. Lac values in the perfused preparation at rest (3-4 mM) were comparable to in vivo measurements (Table 3). In the control series, the intensive exercise protocol triggered a massive Gly breakdown similar to that seen in many in vivo studies (27, 37, 43). Surprisingly, under these in vitro conditions, Gly recovered much faster than in the in vivo studies (Table 3). It took a mere 30 min for muscle Gly to be completely restored to resting levels in the perfused tail trunk, a process that usually takes many hours to complete in vivo. In concert with this change in muscle Gly, there was a >10-fold elevation in muscle Lac accumulation immediately after exercise in the control series (Table 3). However, based on the stoichiometry of 1 Gly = 2 Lac, the buildup of Lac accounted for only about one-half of the Gly depletion at T5. Muscle Lac burden was reduced by 50% during the 30-min recovery period; however, in contrast to Gly, it did not return to the resting level. By T30, Lac clearance accounted for only ~40% of Gly resynthesis. This lack of stoichiometric agreement between Gly and Lac dynamics indicates that part of glyconeogenesis may have originated from sources other than Lac (Table 3).
Under resting conditions, AZICF and AZtot treatments resulted in a significant decrease in muscle Gly storage, whereas extracellular blockade had no effect (Table 3). In parallel to the resting data, Gly in AZtot and AZICF also remained significantly lower than the control value after 30 min of recovery from exhaustive exercise. However, these concentrations did not differ significantly from the respective resting values in each treatment group. In contrast, extracellular CA blockade (BZECF), which was without effect at rest, resulted in a substantially lower muscle Gly concentration at T30 postexercise in comparison to either the control series at this time or the corresponding rest value (Table 3).
Resting muscle Lac concentrations were not significantly affected by CA blockade. Similarly, there were no significant differences in muscle Lac among all four treatment groups 30 min after exercise (Table 3).
At rest, Lac flux rates (Fig. 6) from
perfused muscle (net efflux) were comparable in magnitude but opposite
in sign (net uptake) to those of metabolic protons
(
H+m; Fig. 4) and were unaffected by
CA blockade. After exercise, Lac efflux rates increased approximately
fivefold to a stable value throughout the 30-min postexercise period in
the control series (Fig. 6). All three CA-inhibition treatments
significantly reduced this postexercise elevation by 20-50%. This
attenuation was evident immediately after exercise and throughout
recovery in AZtot and BZECF groups but only at
T30 in the
AZICF group. Overall,
extracellular CA inhibition with
BZECF was most effective in
reducing postexercise Lac efflux (by ~50%). Although these changes
in Lac efflux associated with exercise and CA inhibition are
substantial on a relative basis, it should be appreciated that on an
absolute basis they are small relative to the postexercise Lac burden
in the muscle (Table 3). At most, measured Lac efflux could account for
<15% of Lac clearance from muscle over the 30-min recovery period
(Table 3), so it is not surprising that the effects of CA inhibition on
efflux rate (Fig. 6) were not reflected in muscle Lac concentrations.
|
Effects of CA inhibition on muscle ionic
balance. Ion and fluid levels in perfused trout muscle
at rest (T30) were slightly altered
relative to in vivo values measured at the time of death, with significant elevations in intracellular
Na+ and
K+ as well as in ECFV and a
reduction in intracellular
Cl
concentration (Table
4). In the postexercise control series at
T30, intracellular
Na+ and
K+ concentrations as well as ICFV
were significantly elevated relative to the corresponding values at
rest. CA blockade resulted in changes in intracellular
Na+ concentration in comparison
with values in exercise control, whereas
K+ and
Cl
concentrations remained
unchanged. Among the changes caused by CA inhibition,
AZtot and
BZECF led to significant
depressions in Na+ concentration.
In contrast, AZICF caused
Na+ concentration to increase.
Intra- and extracellular fluid volumes were not significantly different
among control and CA inhibition groups, indicating that fluid shifts do
not occur with CA inhibition.
|
Muscle ionic concentrations may not be a particularly sensitive measure
of changes in the actual flux rates of ions. Ionic flux measurements
themselves were quite variable (Fig. 7),
reflecting the difficulty of measuring small changes in perfusate ion
concentrations against high background concentrations. Nevertheless,
clear trends were seen. At rest, ionic flux rates between the perfusate
and the muscle were not significantly different from zero
(Na+,
Cl
) or slightly negative
(a small net K+ uptake;
Fig. 7). After exercise, net Na+,
Cl
, and
K+ fluxes all increased (i.e., net
losses), with the increase in Cl
flux appearing greatest
at T5 and the increases in
Na+ and
K+ appearing fairly consistent
throughout the recovery period. The changes for both
Na+ and
Cl
were significant
throughout recovery, whereas those for
K+ were significant only at
T5 (Fig. 7). CA inhibition
had little effect on ionic flux rates at rest or on the basic pattern
of changes after exercise, in agreement with the muscle concentration data (Table 4). However at T30,
Na+ losses were significantly
reduced by ~40%, whereas
Cl
and
K+ losses were slightly elevated
relative to the control series by all three blocking treatments.
AZICF also elevated
Cl
loss at rest.
|
| |
DISCUSSION |
|---|
|
|
|---|
Preparation. In previous studies on the effects of exercise on trout white muscle (44, 45), we first exercised the live fish by chasing them to exhaustion and then quickly killed the animal to make the perfused tail trunk preparation. A major improvement in the present study was the development of a method to exercise the resting perfused tail trunk in situ, thereby allowing comparison of measurements before and after exercise. The direct stimulation protocol that we employed reproduced typical postexercise metabolic, respiratory, and acid-base responses shown in many in vivo studies (39, 43, 48). Clearly, the perfused tail trunk does not reflect the exact physiological condition in postexercise muscle in vivo, because it lacks red blood cells and hormones. It eliminates extraneous effects from the presence of CA in other organs and tissues such as the red blood cells, gills and liver, thereby facilitating specific studies on muscle. In particular, the preparation was designed to dissect out the role(s) of CA in the intracellular and extracellular space of fish white muscle with respect to gas exchange, acid-base regulation, and metabolism. An unavoidable consequence of the lack of red blood cell CA in particular is the fact that intracellular PCO2 in the muscle is slightly elevated (e.g., 7.3 vs. 5.5 Torr at rest, probably more after exercise), because PCO2 at the downstream end of the diffusion gradient from myocyte to capillary blood (or perfusate) must be higher in the absence of blood-based catalysis.
The available CA inhibition data indicate that the CA inhibitors were distributed in the fluid compartments for which the experimental protocol was intended (20). The lowest degree of muscle CA inhibition, 38%, was seen for the BZECF treatment (comparable to 40% inhibition by QAS in resting muscle), whereas the AZICF and AZtot treatments produced 78 and 85% inhibition, respectively, as in resting muscle. Because of the method by which the muscle tissue is processed for measurement of CA activity, these inhibition values are conservative estimates of total inhibition (20). CA inhibition in mammalian fibers has been reported to affect various aspects of muscle contraction (27, 39, 43, 44). The mechanical properties of trout muscle could not be measured directly in the perfused tail trunk, but no obvious differences in muscle contraction were observed between the control and CA inhibition treatments with AZ. Note in particular that QAS was used only at rest, and BZECF treatment was started after the end of exercise so as to avoid any such complicating effects.
Another noteworthy aspect of the preparation was its ability to maintain high values of intracellular PCr and ATP and low values of Lac (Table 3) throughout perfusion at rest. These values were close to those measured in vivo at the time of death (Table 3; see Ref. 46 for a comparison of additional resting values for rainbow trout in the literature). Furthermore, after exercise in situ, perfused trunks in the control series rapidly corrected these values (also Gly) back toward resting levels. These observations suggest that the metabolic machinery is intact and that O2 or nutrient supply is not a limiting factor.
As a guide to further discussion, Table 5 summarizes the major effects observed in exercised trout muscle resulting from separate inhibition of extra- and intracellular CA.
|
Effects on gas, acid-base, and Lac
exchanges. In the case of a metabolically active tissue
such as muscle, CA can be important in both gas transport and
intracellular acid-base balance. At rest in trout muscle as well as
mammalian muscle, cytoplasmic CA is believed to function primarily in
maintaining an instantaneous equilibrium between
CO2 and
HCO
3: as
CO2 diffuses across the sarcolemma
out of the cell, it is immediately replaced from the much larger but
less permeable intracellular HCO
3 pool
(18, 19). Membrane-associated CA on the extracellular surface of the
sarcolemma is believed to function in the catalyzed hydration of
excreted CO2 to
HCO
3 in the extracellular boundary
layer, maintaining the transmembrane
PCO2 gradient by preventing the buildup of molecular
CO2. CA inhibition in resting muscle results in lowered CO2
efflux (20).
In exercised trout muscle, CO2 and
H+ production rates are both much
higher than at rest, with H+
production driving HCO
3 dehydration.
CA facilitates rapid establishment of a new equilibrium, and elevated
CO2 excretion is achieved with
very little elevation over resting intramuscular TCO2 concentrations
(Fig. 2B). In fact, after a 1-h
recovery period, fish white muscle often exhibits a depression in
intracellular HCO
3 and
TCO2, because the
CA-catalyzed reactions are driven in the direction of dehydration as a
result of the elevated levels of metabolic protons combined with the rapid removal of molecular CO2
(27, 39, 43, 44).
One of the most apparent differences in the role of trout muscle CA at
rest vs. postexercise appears to be an increase in the importance of
the cytoplasmic CA pool in CO2
efflux. When cytoplasmic CA was inhibited
(AZICF), there was a significant decrease in pHi and a significant
increase in the intracellular PCO2 at
30 min postexercise (Figs. 1 and
2A). At the same time,
TCO2 efflux and intracellular
TCO2 concentrations were not different from those in the control group (Figs.
2B and 3). These results
indicate that with the cytoplasmic pool of CA inhibited, exercised
muscle produces CO2 faster than it
can be excreted; CO2 builds up in
the intracellular space until a new steady state is established in
which a higher intracellular PCO2 is
responsible for maintaining normal
CO2 excretion rates. The decreased
pHi, which is a result of both the
respiratory acidosis and the accumulation of metabolic protons, pushes
the equilibrium of the
CO2-HCO
3-H+
system toward increased PCO2. This
factor appears to be important, because there was a pronounced ICF
acidosis despite the very high intracellular buffer capacity of trout
white muscle (27).
In contrast, CA inhibition did not cause an intracellular acidosis in trout white muscle at rest (20). Rather, CO2 efflux was reduced, at least by extracellular CA inhibition, intracellular PCO2 increased, and the low rate of production and accumulation of CO2 in 30 min was insufficient to produce a new steady state. The large intracellular CA pool, which may be present in excess for CO2 excretion at rest, becomes more important under conditions of peak CO2 load. For respiratory gas exchange at the systemic level in mammals and lower vertebrates (e.g., within the red blood cell), it is generally accepted that CA is present in tremendous excess of requirements for resting CO2 excretion. However, under periods of exercise, and therefore maximal CO2 production, the high levels of CA activity become necessary (e.g., Ref. 38). An analogous situation may exist for individual tissues and cells as well: under conditions of high CO2 production, the large CA pool in the cytoplasm becomes necessary to maintain outward CO2 transport.
In support of this idea, ECF CA inhibition alone (BZECF) did not result in a significant increase in intracellular PCO2 at 30 min postexercise (Fig. 2A), although it did slightly depress the elevated total CO2 efflux (Fig. 3). Conversely, selective inhibition of CA in the ECF in white muscle at rest by QAS did cause an increase in intracellular PCO2 as well as a more marked depression of resting total CO2 efflux (20). So with regard to CO2 efflux, it appears that the relatively small pool of membrane-associated CA on the extracellular surface of the sarcolemma may be swamped by the high levels of CO2 produced during exhaustive exercise and that the intracellular enzyme plays the dominant role at this time.
The additional intracellular acidoses in all of the CA inhibition
treatments (Fig. 1) may have been primarily of metabolic origin,
because in all of them there occurred a sustained influx of
H+m after exercise, in contrast to the
net efflux seen in the control series at this time (Fig. 4). In the absence of CA catalysis, the efflux of metabolic protons (from Lac
production or ATP breakdown) from the muscle cells through the
interstitial fluid into the perfusate cannot be "neutralized" by
HCO
3 in the transit time available. As
a result, pH in the poorly buffered interstitial fluid is lower. Metabolic proton efflux would be reduced because the efflux must fight
a larger net electrochemical gradient, one which strongly favors
influx. Thus net metabolic proton uptake occurs. Earlier we concluded
that Lac efflux from postexercise trout muscle involves a
Lac
-H+
symport and the free diffusion of H-Lac (44, 47), so the reduction in
net Lac efflux caused by all three CA inhibition treatments (Fig. 6)
fits well with the reversal of
H+m fluxes.
However, it is important to understand that the
H+m influx shown in all the CA
inhibition treatments (Fig. 4) is equivalent to (and cannot be
differentiated from) HCO
3 efflux. The
conventional wisdom is that cell membranes in both fish and mammals are
not permeable to bicarbonate ions (40, 41), although
HCO
3 movement can still be carried out
through carrier-mediated transport, i.e., via the
Cl
/HCO
3
or
Lac
/HCO
3
antiport. Earlier we concluded that the Lac
/HCO
3
antiport was not involved in Lac efflux after exercise in trout white
muscle (44, 47), and the present Cl
flux measurements reveal
no differential effects of CA inhibition on net
Cl
exchange (Fig. 7). It
appears more likely that the observed effects really do represent the
movements of metabolic protons. An additional factor in some of the
treatments was a retardation of glycogen resynthesis (Table 3), which
would delay the biochemical removal of metabolic protons.
Regardless, the results clearly demonstrated that muscle CA not only
plays an important role in facilitating
CO2 release from skeletal muscle,
but also influences the metabolic acid movement across muscle cell
membranes after exercise. This may be particularly true in the poorly
vascularized fish white muscle, where interstitial fluid has relatively
low nonbicarbonate buffer capacity and absolute CA activity is also
low. Hence, limitations on the rate at which CO2,
H+, and
HCO
3 come to equilibrium may very well affect their transport from muscle to extracellular space.
These results strongly suggest that CA is involved in both respiratory and metabolic acid-base regulation in trout white muscle. Unlike the present study, AZ infusion in vivo caused an increase in intracellular PCO2 in white muscle of postexercise trout, whereas pHi remained unchanged (7). A direct comparison between the intact fish and the isolated perfused tail trunk may not be very realistic. The perfused tail trunk is a highly simplified system in which white muscle is the sole target of CA inhibition; the intact fish in vivo is a multicompartment system in which CA inhibition can occur simultaneously at multiple sites. Indeed, the blocking protocol used by Currie et al. (7) favored inhibition of erythrocytic CA, causing an increase in PCO2 throughout all compartments of the animal. It is unlikely that the 5- to 30-min period of AZ administration (7) would have been adequate to fully block CA in the muscle.
In control perfused trunk preparations, intracellular acidosis was corrected rapidly after exercise (Fig. 1) relative to in vivo studies (27, 37, 39, 43). This phenomenon is likely associated with a similarly fast glycogen repletion rate (Table 3; see below), which biochemically consumes metabolic acid. The rapid rate in the perfused tail trunk may reflect the absence of "stress" hormones. In trout in vivo, Pagnotta et al. (32) demonstrated that exercise-induced cortisol mobilization hinders both glycogen resynthesis from Lac and postexercise acid clearance. The adaptive significance is unclear. However cortisol "removal" by pharmacological intervention greatly accelerates the in vivo correction rate to a level comparable to that seen in vitro. It would be informative to confirm this conclusion by the addition of cortisol to the perfusate in the tail trunk preparation.
Effects on glycogen, energy-rich phosphate, and
ammonia metabolism. Today, it is generally accepted
that Lac release from muscle and transport to the liver for
hepatic-based gluconeogenesis (the Cori cycle) are less important in
fish than in mammals. Instead, most fish retain a large portion of the
Lac synthesized during exhaustive exercise within white muscle, where
it is later used as a carbon source for in situ glycogen resynthesis
(14, 26, 48). The rapid restoration of Gly and partial clearance of Lac by the perfused trunk muscle in the present study (Table 3) further supports this view, However, it must be pointed out that the glucose in
the perfusate (as in vivo) could have potentially provided the
substrate for this glycogen replenishment, although there are multiple
lines of evidence that oppose this interpretation (26, 48). What
remains particularly unclear at present is the biochemical pathway by
which Lac is converted back to glycogen in fish muscle; an involvement
of CA for HCO
3 supply might be
expected in several of the proposed routes (see introduction).
Regardless, we would not necessarily expect CA inhibition to have the
same effects on Lac transport and metabolism in fish as in mammals.
Geers et al. (9) reported that in mammalian muscle, CA inhibition with
chlorazolamide led to marked increases in both muscle Lac concentration
and efflux rate into blood, effects which were not seen in the perfused
trout trunk (Table 3, Fig. 6) or in vivo (7). Indeed CA inhibition
reduced Lac release from the perfused preparation, perhaps through the
effect on proton gradient discussed earlier.
The depressed resting levels of Gly in the fish that had been pretreated with AZ (AZtot and AZICF groups), but not in QAS-treated fish (Table 3), show that intracellular CA activity is essential to maintenance of normal glycogen stores and are consistent with findings in mammalian muscle (6, 34). More importantly, all three CA inhibition treatments slowed the rate of Gly resynthesis after exercise (Table 3). Interpretation is complex, however, because Lac clearance was not affected, and furthermore Gly resynthesis substantially exceeded Lac removal (Table 3), suggesting that other fuels were used. At any one time, the Gly store is a function of synthesis and degradation rates (i.e., glycolysis), so potential effects on the latter must also be considered. One possible interpretation is that the pathway of Gly resynthesis involves carboxylation of pyruvate via pyruvate carboxylase or via the reversal of malic enzyme rather than reversal of pyruvate kinase (see introduction). However, the lower pHi accompanying CA inhibition (Fig. 1) may also be an important factor; Walsh and Milligan (42) summarized circumstantial evidence indicating that acidosis itself inhibits both glycogenesis and gluconeogenesis from Lac in trout tissues. Clearly, there is a need for more detailed analyses in a simpler system (i.e., in the test tube); the important lesson from the present study is that muscle CA plays a critically direct or indirect role and should be considered in such systems.
ATP concentrations in white muscle were not affected by CA inhibition either at rest or after exercise (Table 3). Curiously though, extracellular CA inhibition greatly lowered intracellular PCr at rest, whereas intracellular CA inhibition had no effect. This may be associated with the observation that at rest intracellular PCO2 was elevated only by extracellular CA inhibition and not by intracellular blockade (20). However, intracellular CA inhibition, which did elevate intracellular PCO2 after exercise, appeared to become extremely potent in delaying or preventing PCr recovery after exercise. This depletion or slower resynthesis of PCr may be due to end product inhibition on pyruvate dehydrogenase caused by PCO2 buildup. In rat muscle, similar effects of CA inhibition (9, 11) and respiratory acidosis (35) in causing PCr depletion have been reported. Although AZ has previously been shown to result in substantial limitation of the carboxylation reaction in mammalian preparation (16), a similar effect of intracellular CA inhibition may also result in end product inhibition of decarboxylation reactions such as that catalyzed by pyruvate dehydrogenase. At least in mammals, the resynthesis of PCr has been shown to be dependent on the rate of ATP turnover supplied by the maximal activity of the TCA cycle (31). Therefore in end product inhibition of pyruvate dehydrogenase the rate-limiting step would be expected to reduce the rate of ATP synthesis and, hence, PCr regeneration. Additionally or alternately, the well-known effect of creatine kinase activation by low pHi and ADP (21) may have been involved. Thus the intracellular acidosis res